BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/22/2021 12:14:42 PM | Browse: 1014 | Download: 2198
Publication Name World Journal of Clinical Cases
Manuscript ID 62271
Country South Korea
ISSN 2307-8960 (online)
Open Access This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/
Copyright © The Author(s) 2021. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Gastroenterology & Hepatology
Manuscript Type Minireviews
Article Title Immunotherapy for pancreatic cancer
Manuscript Source Invited Manuscript
All Author List Jai Hoon Yoon, Ye-Ji Jung and Sung-Hoon Moon
ORCID
Author(s) ORCID Number
Jai Hoon Yoon http://orcid.org/0000-0003-3194-5149
Ye-Ji Jung http://orcid.org/0000-0002-9629-1062
Sung-Hoon Moon http://orcid.org/0000-0002-7879-3114
Funding Agency and Grant Number
Corresponding Author Sung-Hoon Moon, MD, PhD, Associate Professor, Department of Internal Medicine, University of Hallym College of Medicine, Hallym University Sacred Heart Hospital, 22 Gwanpyeong-ro 170-gil, Dongan-gu, Anyang 14068, South Korea. endomoon@hallym.or.kr
Key Words Pancreatic adenocarcinoma; Pancreatic cancer; Immunotherapy; Immune checkpoint inhibitor
Core Tip This review article addressed the role of immune cells in the development of pancreatic cancer, the tumor microenvironment, the cancer immunity cycle, the mechanisms and efficacies of immunotherapeutic drugs in pancreatic cancer, and the response criteria for use in trials aimed at testing immunotherapeutics. The strength of this article includes 2 characteristic tables for basic mechanisms and clinical outcomes related with pancreatic cancer immunotherapy.
Publish Date 2021-04-22 12:14
Citation Yoon JH, Jung YJ, Moon SH. Immunotherapy for Pancreatic Cancer. World J Clin Cases 2021; 9(13): 2969-2982
URL https://www.wjgnet.com/2307-8960/full/v9/i13/2969.htm
DOI https://dx.doi.org/10.12998/wjcc.v9.i13.2969
Full Article (PDF) WJCC-9-2969.pdf
Full Article (Word) WJCC-9-2969.docx